
Greg’s story
Greg thought of himself as healthy and active when he went in for a routine heart ablation in early 2023. A few days later, tests revealed a mass on his pancreas. The diagnosis was pancreatic cancer.
When his surgeon mentioned a clinical trial called NEO-IMPACT, Greg chose to take part, knowing it could offer an approach beyond standard treatment. Through the trial, Greg received treatment he would not otherwise have been able to access.
The chemotherapy was hard. Greg lost weight and developed neuropathy that persists today. Recovery from surgery was slow, and he had to learn his body's new limitations. But then came the scans with unexpected news: the cancer was completely gone.












